
ATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotype

ATLANTA, GEORGIA—The new tyrosine kinase ibrutinib has shown “profound activity” in patients with chronic lymphocytic leukaemia—according to research presented at the American Society of H

SAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated with chemotherapy as well as surgery and

ATLANTA, GA—Solid confirmation of target hematocrit to minimise clotting risks in polycythemia vera has been presented at the American Society of Hematology annual meeting and simultaneously published

SAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower overall doses of radiation — were just has as effective for treating breast cancer in the UK START trial conducted among 445

ATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotype

Other headlines: – Hypofractioned radiotherapy safe and effective for early breast cancer. – Chromosomal microarray slowly making its way into prenatal diagnosis. – Dose-response rel

Other headlines: – Automated phone and email reminders increase prescription adherence. – Routine health checks do not benefit the general population. – New tyrosine kinase inhibitor

ATLANTA—Schistosomiasis — also known as bilharzia — could be eliminated from Africa and elsewhere by using two actions together: making simple improvements in sanitation and hygiene and treating infec

ATLANTA—Schistosomiasis — also known as bilharzia — could be eliminated from Africa and elsewhere by using two actions together: making simple improvements in water-supply sanitation and hygiene and

Other headlines: – Long-term benefits of pallidal neurostimulation in patients with severe idiopathic dystonia. – Long term survival benefits of endovascular repair similar to those of ope

ATLANTA—The RTS,S/AS01 candidate malaria vaccine — being tested in seven African countries — is safe, and gave protection to a third of all babies vaccinated between the ages of six and 12 weeks durin